LENSAR, INC. (LNSR) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $2.13M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $2.24M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$7.58M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$6.29M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | $2.13M | (m) | $14.72M | (m) | (m) | -$127.00K* | (m) | $1.27M | $6.14M | $0.00 |
| 2026-03-31 | Reported | (m) | $2.24M | (m) | $11.75M | (m) | (m) | -$4.27M | (m) | $1.39M | $2.53M | $0.00 |
| 2025-09-30 | Reported | (m) | -$7.58M | (m) | $12.76M | (m) | $0.00* | -$3.51M* | (m) | $1.37M | $12.02M | $0.00 |
| 2025-06-30 | Reported | (m) | -$6.29M | (m) | $12.29M | (m) | $77.00K* | -$5.00M* | (m) | $1.43M | $11.66M | $0.00 |
| 2025-03-31 | Reported | (m) | -$5.79M | (m) | $12.28M | (m) | $6.00K | -$6.94M | (m) | $1.53M | $11.15M | $0.00 |
| 2024-09-30 | Reported | (m) | -$1.25M | (m) | $11.81M | (m) | $20.00K* | $3.15M* | (m) | $1.20M | $6.08M | $0.00 |
| 2024-06-30 | Reported | (m) | -$5.28M | (m) | $10.68M | (m) | $113.00K* | -$3.78M* | (m) | $1.35M | $6.78M | $0.00 |
| 2024-03-31 | Reported | (m) | -$2.85M | (m) | $8.64M | (m) | $20.00K | -$5.31M | (m) | $1.44M | $6.80M | $0.00 |
| 2023-09-30 | Reported | (m) | -$2.04M | (m) | $8.27M | (m) | $2.00K* | -$339.00K* | (m) | $1.53M | $5.12M | $0.00 |
| 2023-06-30 | Reported | (m) | -$2.87M | (m) | $10.32M | (m) | $181.00K* | -$2.14M* | (m) | $1.50M | $7.85M | $0.00 |
| 2023-03-31 | Reported | (m) | -$4.36M | (m) | $6.62M | (m) | $8.00K | -$6.70M | (m) | $1.65M | $6.75M | $0.00 |
| 2022-09-30 | Reported | (m) | -$4.08M | (m) | $6.28M | (m) | $2.00K* | -$4.70M* | (m) | $1.58M | $6.12M | $0.00 |
| 2022-06-30 | Reported | (m) | -$6.80M | (m) | $6.62M | (m) | $10.00K* | -$2.79M* | (m) | $3.83M | $7.57M | $0.00 |
| 2022-03-31 | Reported | (m) | -$6.68M | (m) | $7.94M | (m) | $46.00K | -$2.61M | (m) | $4.79M | $6.28M | $0.00 |
| 2021-09-30 | Reported | (m) | -$6.17M | (m) | $6.99M | (m) | $64.00K* | -$2.15M* | (m) | $3.18M | $6.52M | $0.00 |
| 2021-06-30 | Reported | (m) | -$4.38M | (m) | $6.78M | (m) | $20.00K* | -$1.46M* | (m) | $3.01M | $5.52M | $0.00 |
| 2021-03-31 | Reported | (m) | -$5.20M | (m) | $5.93M | (m) | $114.00K | -$4.62M | (m) | $2.75M | $6.04M | $0.00 |
| 2020-09-30 | Reported | (m) | -$4.71M | (m) | $6.07M | (m) | $6.00K* | -$55.00K* | (m) | $2.00M | $6.29M | $0.00 |
| 2020-06-30 | Reported | (m) | -$3.84M | (m) | $4.58M | (m) | $152.00K* | -$5.38M* | (m) | $1.43M | $4.04M | $0.00 |
| 2020-03-31 | Reported | (m) | -$3.10M | (m) | $4.93M | (m) | $103.00K | -$6.36M | (m) | $1.57M | $4.78M | $0.00 |
| 2019-09-30 | Reported | (m) | -$5.34M | (m) | $6.96M | (m) | (m) | (m) | (m) | $4.33M | $3.96M | $0.00 |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$24.58M | (m) | $51.66M | (m) | $83.00K | -$14.83M | (m) | $5.62M | $45.16M | (m) |
| 2024-12-31 | Reported | (m) | -$10.66M | (m) | $45.96M | (m) | $156.00K | -$2.27M | (m) | $5.33M | $26.49M | (m) |
| 2023-12-31 | Reported | (m) | -$12.23M | (m) | $35.72M | (m) | $236.00K | -$9.66M | (m) | $6.14M | $26.10M | (m) |
| 2022-12-31 | Reported | (m) | -$20.18M | (m) | $29.44M | (m) | $115.00K | -$14.86M | (m) | $11.81M | $27.17M | (m) |
| 2021-12-31 | Reported | (m) | -$19.65M | (m) | $29.49M | (m) | $354.00K | -$8.97M | (m) | $12.36M | $23.89M | (m) |
| 2020-12-31 | Reported | (m) | -$18.50M | (m) | $22.78M | (m) | $366.00K | -$13.79M | (m) | $7.55M | $23.77M | (m) |
| 2019-12-31 | Reported | (m) | -$12.71M | (m) | $26.35M | (m) | $389.00K | -$12.59M | (m) | $7.57M | $17.15M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |